Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

November 01, 2020; Volume 98,Issue 5

Minireview

  • You have access
    Notch1 in Cancer Therapy: Possible Clinical Implications and Challenges
    L. Gharaibeh, N. Elmadany, K. Alwosaibai and W. Alshaer
    Molecular Pharmacology November 2020, 98 (5) 559-576; DOI: https://doi.org/10.1124/molpharm.120.000006
  • You have access
    Functions of the CXCL12 Receptor ACKR3/CXCR7—What Has Been Perceived and What Has Been Overlooked
    Christian Koch and Jürgen Engele
    Molecular Pharmacology November 2020, 98 (5) 577-585; DOI: https://doi.org/10.1124/molpharm.120.000056
  • Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection
    You have access
    Heparin-binding Peptides as Novel Therapies to Stop SARS-CoV-2 Cellular Entry and Infection
    Omid Tavassoly, Farinaz Safavi and Iman Tavassoly
    Molecular Pharmacology November 2020, 98 (5) 612-619; DOI: https://doi.org/10.1124/molpharm.120.000098
  • You have access
    Molecular Pharmacology of NRH:Quinone Oxidoreductase 2: A Detoxifying Enzyme Acting as an Undercover Toxifying Enzyme
    Elzbieta Janda, Françoise Nepveu, Barbara Calamini, Gilles Ferry and Jean A. Boutin
    Molecular Pharmacology November 2020, 98 (5) 620-633; DOI: https://doi.org/10.1124/molpharm.120.000105

Articles

  • You have access
    Structure of Cytochrome P450 2C9*2 in Complex with Losartan: Insights into the Effect of Genetic Polymorphism
    Sonia J. Parikh, Chiara M. Evans, Juliet O. Obi, Qinghai Zhang, Keiko Maekawa, Karen C. Glass and Manish B. Shah
    Molecular Pharmacology November 2020, 98 (5) 529-539; DOI: https://doi.org/10.1124/molpharm.120.000042
  • Open Access
    GS-967 and Eleclazine Block Sodium Channels in Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
    Franck Potet, Defne E. Egecioglu, Paul W. Burridge and Alfred L. George
    Molecular Pharmacology November 2020, 98 (5) 540-547; DOI: https://doi.org/10.1124/molpharm.120.000048
  • You have access
    Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action
    Kathryn L. Reichard, Keionna A. Newton, Zeena M.G. Rivera, Paulo M. Sotero de Menezes, Selena S. Schattauer, Benjamin B. Land and Charles Chavkin
    Molecular Pharmacology November 2020, 98 (5) 548-558; DOI: https://doi.org/10.1124/molpharm.120.000124
  • You have access
    Transient Receptor Potential Ankyrin-1 and Vanilloid-3 Differentially Regulate Endoplasmic Reticulum Stress and Cytotoxicity in Human Lung Epithelial Cells After Pneumotoxic Wood Smoke Particle Exposure
    Nam D. Nguyen, Tosifa A. Memon, Katherine L. Burrell, Marysol Almestica-Roberts, Emmanuel Rapp, Lili Sun, Abigail F. Scott, Joseph E. Rower, Cassandra E. Deering-Rice and Christopher A. Reilly
    Molecular Pharmacology November 2020, 98 (5) 586-597; DOI: https://doi.org/10.1124/molpharm.120.000047
  • Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias
    Open Access
    Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias
    Elsa Martins, Hellena Brodier, Irène Rossitto-Borlat, Ilke Ilgaz, Mélanie Villard and Oliver Hartley
    Molecular Pharmacology November 2020, 98 (5) 599-611; DOI: https://doi.org/10.1124/molpharm.120.000036
  • Antiepileptic Drug–Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator–Activated Receptor <em>α</em> and Peroxisome Proliferator–Activated Receptor <em>γ</em> Coactivator 1<em>α</em>–Dependent Gene Expression to Increase Blood Triglyceride Levels
    You have access
    Antiepileptic Drug–Activated Constitutive Androstane Receptor Inhibits Peroxisome Proliferator–Activated Receptor α and Peroxisome Proliferator–Activated Receptor γ Coactivator 1α–Dependent Gene Expression to Increase Blood Triglyceride Levels
    Ryota Shizu, Yuta Otsuka, Kanako Ezaki, Chizuru Ishii, Shingo Arakawa, Yuto Amaike, Taiki Abe, Takuomi Hosaka, Takamitsu Sasaki, Yuichiro Kanno, Masaaki Miyata, Yasushi Yamazoe and Kouichi Yoshinari
    Molecular Pharmacology November 2020, 98 (5) 634-647; DOI: https://doi.org/10.1124/molpharm.120.000103

Erratum

  • You have access
    Correction to “Commentary on: Does COVID19 Infect the Brain? If So, Smokers Might Be at a Higher Risk”
    Molecular Pharmacology November 2020, 98 (5) 598; DOI: https://doi.org/10.1124/molpharm.120.000049err
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 98 (5)
Molecular Pharmacology
Vol. 98, Issue 5
1 Nov 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireview
  • Articles
  • Erratum
  • Most Read
Loading
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Histamine H3 Receptor
  • Peptide Nanoformulations against the Tumor Microenvironment
  • Characterization of Vixotrigine
  • Dehydrocrenatidine Is a Novel JAK Inhibitor
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics